AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Operation warp speed vaccine2/18/2023 ![]() ![]() Increasing the range of antivirals requires government funding for drug development and clinical trials. They are Molnupiravir by drugmaker Merck, and Paxlovid by Pfizer. Surprisingly, only two antiviral treatments specific for SARS-CoV-2 have been produced and approved for emergency use in the United States, as well as in other countries. There is abundant room to speed the development of effective treatments. Treatments are not only an important instrument in fighting pandemics but can be critical to the control of viral transmission. One reason is that even updated vaccines will not likely overcome viral mutations providing full protection from infection. It is now time to learn the lesson of that achievement and devote similar government resources to expanding treatment of the SARS-CoV-2 virus disease as the best way to protect the health of the world population. In the United States, the vaccine success story resulted largely from massive US government intervention and expenditure under Operation Warp Speed. But the production and distribution of vaccines-in many countries at least-have largely succeeded in reducing deaths, hospitalizations, and severe cases of the disease, despite the proliferation of coronavirus mutations and the refusal of too many Americans to take the vaccine. More than two years have passed since the virus that causes COVID-19 spread across the globe, causing more than a million deaths in the United States alone. ![]()
0 Comments
Read More
Leave a Reply. |